SEC Filing Summary: CopyTele, Inc. (Form 10-K)
Business Context and Reporting Period
This Annual Report covers the fiscal year ended October 31, 2002, for CopyTele, Inc. (Note: The request metadata listed "Anixa Biosciences Inc," but the filing text explicitly identifies the registrant as CopyTele, Inc.). The company operates in two primary segments: the development and marketing of encryption products for voice, fax, and data security, and the development of flat-panel display technologies, specifically Field Emission Displays (FED) and E-Paper.
During the period, the company transitioned from a development-stage enterprise to an operating company. A significant event was the termination of its Joint Cooperating Agreement with Futaba Corporation in June 2002, which had been a major revenue source. The company continues to collaborate with Volga Svet Ltd. on display technology.
Key Financial Metrics
| Metric | Fiscal 2002 | Fiscal 2001 |
|---|---|---|
| Total Revenue | $5,186,694 | $1,690,768 |
| Gross Profit | $3,315,636 | $993,129 |
| Net Loss | $(3,285,240) | $(3,571,957) |
| Net Loss Per Share (Basic/Diluted) | $(0.05) | $(0.06) |
| Research & Development Expenses | $1,625,974 | $2,324,979 |
| Cash Used in Operating Activities | $(431,471) | $(717,845) |
| Cash and Cash Equivalents (End of Period) | $854,822 | $1,316,860 |
| Shareholders' Equity | $2,317,490 | $4,166,526 |
| Long-Term Obligations | $0 | $0 |
Material Changes vs. Prior Period
- Revenue Composition: Total revenue increased significantly due to the recognition of $4.54 million in collaborative agreement revenue from Futaba Corporation (88% of total revenue). In contrast, product sales revenue from encryption devices decreased slightly to $645,027 from $732,435 in the prior year.
- Impairment Loss: The company recognized a non-cash impairment loss of approximately $2.82 million related to unused commercial trade barter credits. This charge was recorded because the termination of the Futaba agreement negatively impacted cash flow, making it uncertain if the company could pay the cash portion required to utilize these credits.
- Operating Expenses: Research and development expenses decreased by approximately $699,000, largely because costs related to FED technology were reclassified as cost of revenue during the Futaba agreement term. Selling, general, and administrative expenses decreased by approximately $94,000.
- Liquidity: Cash and cash equivalents decreased by approximately $462,000 to $855,000. Working capital increased to approximately $2.24 million, driven by the reduction in deferred revenue as Futaba payments were recognized.
Guidance, Outlook, and Risks
- Going Concern: The independent auditors (Grant Thornton LLP) issued a "going concern" opinion. The company has incurred net losses since inception and has an accumulated deficit of approximately $62 million. Management believes existing cash and receivables will sustain operations until at least the end of the first quarter of fiscal 2004, but additional funding will likely be required thereafter.
- Financing Needs: The company anticipates needing additional funds for marketing, production, and R&D. It may seek to sell debt or equity securities, which could result in dilution to stockholders. There are no current arrangements for additional financing.
- Nasdaq Delisting Risk: The company's common stock is listed on the Nasdaq SmallCap Market. It failed to meet the minimum closing bid price of $1.00 per share (closing at $0.17 as of Feb 6, 2003) and stockholders' equity requirements ($2.32 million vs. $2.5 million required). The company faces potential delisting and intends to request a hearing if notified.
- Technology Commercialization: The company is negotiating with potential purchasers for high-brightness displays produced by Volga. However, there is no assurance that these displays can be produced commercially or that revenue will be generated. The termination of the Futaba agreement created uncertainty regarding future display development funding.
Investor Verification Checklist
- Going Concern Status: Verify the company's ability to secure additional financing before the first quarter of fiscal 2004 to avoid insolvency.
- Nasdaq Compliance: Monitor the status of the Nasdaq delisting proceedings and the company's plan to regain compliance with listing standards.
- Revenue Sustainability: Assess the likelihood of generating revenue from the Volga display partnership and encryption product sales in the absence of the Futaba agreement.
- Inventory Valuation: Review the $1.3 million inventory balance, noting the $100,000 provision for slow-moving inventory and the risk of further write-downs if sales do not materialize.
- Management Compensation: Note that the CEO and President have waived cash salaries since 1985, relying on stock options; verify if this arrangement remains sustainable for retaining key personnel.